Grail, a deep-pocketed startup, outlines its plans for a blood test to detect cancer

Grail, a deep-pocketed startup, outlines its plans for a blood test to detect cancer

Source: 
Stat
snippet: 

Could a blood test detect cancer in healthy people? Grail, a Menlo Park, Calif.-based company, has raised $1.6 billion in venture capital to prove the answer is yes. And at the world’s largest meeting of cancer doctors, the company is unveiling data that seem designed to assuage the concerns and fears of its doubters and critics. But outside experts emphasize there is still a long way to go.